Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

EU Project Aims to Cure Type 1 Diabetes

April 4, 2016 9:14 am | by Goethe University Frankfurt | News | Comments

The number of children in Europe and the USA with type 1 diabetes is growing by four percent each year. Read more...


Retooled Bayer Expands US Business

April 4, 2016 9:12 am | by Linda A. Johnson, AP Business Writer | News | Comments

The German conglomerate that invented aspirin over a century ago wants to take over much more of your medicine cabinet. Read more...


Takeda Launches Multi-Year IBD Research Partnership

April 4, 2016 9:12 am | News | Comments

Takeda aims to pave the way for translating science into pioneering treatment paradigms and patient-centered support. Read more...


EMA Recommends GSK's Groundbreaking Gene Therapy

April 4, 2016 9:04 am | by Ryan Bushey, Digital Editor | News | Comments

An estimated 15 children are born with this year condition per year in Europe. Read more...


Pricey Prostate Cancer Drug's Makers Targeted by Congress

April 2, 2016 10:30 am | by Linda A. Johnson, AP Business Writer | News | Comments

Lawmakers again are targeting the pharmaceutical industry over sky-high prescription drug prices. Read more...


How Aspirin Does More Than Kill Pain

April 1, 2016 1:50 pm | by Emma Young, Mosaic | News | Comments

The painkiller has potential as an anticancer drug.


Perfecting a Viral Pack Mule

April 1, 2016 1:38 pm | by Scripps Research Institute | News | Comments

Viruses aren’t always bad.


Drug Discovery Spotlight: Zika-Microcephaly Link Confirmed; Abortion Pill; Ovarian Cancer Therapy Fails

April 1, 2016 12:57 pm | by Stephanie Guzowski, Editor | News | Comments

Welcome to Drug Discovery Spotlight — we’ve rounded up this week’s top news, trending headlines, and all-around interesting reads.


New Study Implicates Unusual Class of Circular RNAs in Cancer

April 1, 2016 10:33 am | by Beth Israel Deaconess Medical Center | News | Comments

Cancer cells are notorious for their genomes gone haywire, often yielding fusion proteins -- mash-ups of two disparate genes that, once united, assume new and harmful capabilities. Exactly how such genome scrambling impacts RNA has been largely unexplored. Read more...

Acne Treatment: Antibiotics Don’t Need to Kill Bacteria to Clear Up Your Skin

April 1, 2016 10:29 am | by The Conversation | News | Comments

Antibiotics may be prescribed at higher doses than what is really needed to treat acne. Read more...


Study Reveals the Possibility of Curbing Synapse Loss in Alzheimer's

April 1, 2016 10:20 am | by Boston Children's Hospital | News | Comments

Researchers at Boston Children's Hospital show how brain connections, or synapses, are lost early in Alzheimer's disease and demonstrate that the process starts -- and could potentially be halted -- before telltale plaques accumulate in the brain. Read more...


Chronic Lyme Not Helped by Long-term Antibiotics

April 1, 2016 10:15 am | by Seth Augenstein, Digital Reporter | News | Comments

Long-term treatment with antibiotics does not improve the symptoms of chronic Lyme Disease, according to a new study by a Dutch team. Read more...


Compact Drug Synthesizer Could Revolutionize Drug Delivery

April 1, 2016 10:09 am | by American Association for the Advancement of Science | News | Comments

Researchers have developed a system the size of a household fridge that can synthesize a variety of pharmaceuticals in short periods of time, including an antihistamine, an antidepressant, a common local anesthetic, and a central nervous system depressant. Read more...


The Other Opioid Crisis

April 1, 2016 8:38 am | by Luke Messac, University of Pennsylvania, The Conversation | News | Comments

There are two opioid crises in the world today. Read more...


Tick Saliva Could Help Make New Blood Disorder Treatment

April 1, 2016 8:31 am | by Monash University | News | Comments

Scientists found a connection between tick saliva proteins and eculizumab. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.